Physician profile
Jeffrey D Kellar
NPI 1659385821
$8,992.96
in general payments reported to CMS, 2019-2025
18 companies · $7,315 in 2025
The $7,315 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $59.42 · 2021: $225 · 2022: $171 · 2023: $1,071 · 2024: $39.09 · 2025: $7,315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,020 · Travel and Lodging: $3,710 · Food and Beverage: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,020.00 |
| Travel and Lodging | $3,709.65 |
| Food and Beverage | $695.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,268.48 | 2025 | |
| Zimmer Biomet Holdings, INC. | $958.55 | 2023 | Advantagerib |
| Csl Behring | $208.57 | 2021-2024 | Kcentra |
| Davol INC. | $85.27 | 2020-2022 | |
| Angiodynamics, INC. | $74.80 | 2019-2021 | |
| Ethicon US, LLC | $52.53 | 2019 | |
| Teleflex LLC | $47.99 | 2022-2023 | Quikclot |
| Polynovo North America LLC | $47.05 | 2023-2025 | Novosorb Btm |
| Kci USA, INC. | $43.50 | 2021-2023 | Prevena |
| Pacira Pharmaceuticals Incorporated | $41.22 | 2021-2023 | Exparel |
| Innocoll Pharmaceuticals Limited | $35.32 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $25.73 | 2025 | |
| Smith+Nephew, INC. | $19.30 | 2022 | |
| Philips North America LLC | $19.09 | 2024 | (792) Multi Modality Ivus Other Systems |
| Midsouth Orthopedics INC. | $18.91 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $17.70 | 2021 | |
| Covidien LP | $15.96 | 2019 | |
| Getinge USA Sales, LLC | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Kellar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.